PDS Biotechnology Corp
PDSB· Nasdaq
Filed May 13, 2021 · 10-Q · 43 days after period end · 0001140361-21-017113
| Metric | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 |
|---|---|---|---|---|
| Net Income | -$3.05M | -$3.99M | $6.82M | -$737.89K |
| EPS Diluted | -$0.14 | -$0.39 | $1.47 | -$0.24 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR
ended Mar 31, 2021 · filed May 13, 2021 · 43 d after period end